The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis
Mengying Zhang, Ting Jiao, Yuwan Ma, Shuanying Yang
Springer Nature ·
2026-04-27
· DOI 10.1186/s12885-026-16104-0
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Mengying Zhang, Ting Jiao, Yuwan Ma, Shuanying Yang. The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-16104-0. – URL: https://doi.org/10.1186/s12885-026-16104-0
Mengying Zhang, Ting Jiao, Yuwan Ma, & Shuanying Yang (2026). The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis. BMC Cancer. https://doi.org/10.1186/s12885-026-16104-0
Mengying Zhang, et al. “The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis.” BMC Cancer, 2026. doi:10.1186/s12885-026-16104-0.
@article{Zhang2026,
title = {The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis},
author = {Zhang, Mengying and Jiao, Ting and Ma, Yuwan and Yang, Shuanying},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-16104-0},
url = {https://doi.org/10.1186/s12885-026-16104-0}
}